Shuying Zhao

Shuying Zhao

Auto-generated profile, based on publicly available information

Shuying Zhao

School of Public Health, Shandong Medical and Pharmaceutical University, Yantai 264003, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2024 in Heliyon
Verified
Journal Article
Open access
WMWei Mi
Wei Mi
ZHZhiyong Hu
Zhiyong Hu
SZShuying Zhao
Shuying Zhao
WWWei Wang
Wei Wang
WLWu Lian
Wu Lian
TSTala Shi
Tala Shi
This study investigated the effects of purple sweet potato anthocyanins (PSPA) in a type 2 diabetes mellitus (T2DM) mouse model. Sixty-five male mice were randomly divided into one control group and four experimental groups, which were fed with a high-fat diet and intraperitoneally injected with streptozotocin (STZ) to induce T2DM. The model mice were treated with 0 (M), 227.5 (LP), 455 (MP), or 910 (HP) mg/kg PSPA for ten days. ELISA, 16S rRNA sequencing, and hematoxylin and eosin staining were used to assess blood biochemical parameters, gut microbial composition, and liver tissue structure, respectively. The FBG concentration was significantly decreased in the LP (6.32 ± 1.05 mmol/L), MP (6.32 ± 1.05 mmol/L), and HP (5.65 ± 0.83 mmol/L) groups; the glycosylated hemoglobin levels were significantly decreased in the HP group (14.43 ± 7.12 pg/mL) compared with that in the M group (8.08 ± 1.04 mmol/L; 27.20 ± 7.72 pg/mL; P < 0.05). The PSPA treated groups also increased blood glutathione levels compared with M. PSPA significantly affected gut microbial diversity. The Firmicutes/Bacteroidetes ratio decreased by 38.9 %, 49.2 %, and 15.9 % in the LP, MP, and HP groups compared with that in the M group (0.62). The PSPAs treated groups showed an increased relative abundance of Lachnospiraceae_Clostridium, Butyricimonas, and Akkermansia and decreased abundance of nine bacterial genera, including Staphylococcus. PSPA reduced blood glucose levels, increased serum antioxidant enzymes, and optimized the diversity and structure of the gut microbiota in mice with T2DM.

26 October 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
CLChenchen Li
Chenchen Li
SZShuying Zhao
Shuying Zhao
WMWei Mi
Wei Mi
ZHzhiyong hu
zhiyong hu
TSTala Shi
Tala Shi
Background: Dietary intervention could modulate gut microbiota, improve insulin resistance status, and play a key role in blood glucose regulation. Objective: This study investigated the regulatory effects of paeonidin- and cyanidin-rich fractions (PCs) on gut microbiota and serum metabolites in high-fat, high-sucrose diet/streptozotocin-induced type 2 diabetes mellitus (T2DM) rats. Method: Following a 14-day intragastric PC administration (25 mg/kg/day), non-targeted metabolomics and 16S rDNA sequencing were performed. Results: PC intervention significantly reduced water intake, and even the effects on lipids were limited. Among 83 differential serum metabolites, PC restored 28, including tauroursodeoxycholic acid (TUDCA) and lysophosphatidylcholines, while decreasing glycated branched-chain amino acid derivatives. PC-enriched Bifidobacterium, Sediminibacterium, SC-I-84, and Fusicatenibacter, which positively correlated with TUDCA. Additionally, PC upregulated insulin secretion and p53 signaling pathways with increased RYR2 and FAS, while downregulating pentose and glucuronate interconversion enzymes (UxaC, XylB). Conclusions: These findings suggest that the amelioration of glycolipid metabolic disorders and insulin secretion defects by PC may be associated with a synergistic gut microbiota-metabolite-enzyme axis, potentially involving Bifidobacterium-mediated TUDCA elevation and downstream modulation of metabolic enzymes.